Reference is made to the Governance Agreement (the “Governance Agreement”), dated as of March 3, 2014, among Glaxo Group Limited (“GSK”) and Theravance Biopharma, Inc. (“Biopharma” and, together with GSK, the “Parties”) and Biopharma’s notice to GSK...Governance Agreement • September 11th, 2015 • Theravance Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS ORDINARY SHARE PURCHASE AGREEMENT (the “Agreement”) is made as of the [ ] day of [ ], 2015, by and among Theravance Biopharma, Inc., a Cayman Islands exempted company (the “Company”) and Glaxo Group Limited, a limited liability company organized under the laws of England and Wales (“GSK”).
